Loading...

Categories

28 Saudi Arabia Pharmaceuticals Reports

Saudi Arabia Diabetes Drugs Industry

Country Covered: Saudi Arabia

Study Period: 2018 - 2029

Major Players: AstraZeneca, Boehringer Ingelheim, Merck and Co., Novo Nordisk A/S, Sanofi Aventis

Saudi Arabia Active Pharmaceutical Ingredients (API) Market

Country Covered: Saudi Arabia

Study Period: 2019 - 2029

Major Players: Pfizer, Inc., Aurobindo Pharma, Novartis AG, BASF SE, Viatris Inc.

Middle East and Africa Glucagon-like Peptide-1 (GLP-1) Agonists Market

Country Covered: Saudi Arabia

Study Period: 2019- 2029

Major Players: AstraZeneca, Sanofi, Eli Lilly and Company, Novo Nordisk A/S, Pfizer Inc.

Middle East and Africa Diabetes Treatment Market

Country Covered: Saudi Arabia

Study Period: 2019- 2029

Major Players: Novo Nordisk, Sanofi, Eli lilly, Wockhardt, Pfizer

MEA Sodium-dependent Glucose Co-transporter 2 Inhibitors Market

Country Covered: Saudi Arabia

Study Period: 2019 - 2029

Major Players: Astrazeneca, Bristol-Myers Squibb, Eli Lilly, Janssen, Astellas

Middle East And Africa Biguanide Market

Country Covered: Saudi Arabia

Study Period: 2018 - 2029

Major Players: Bristol Myers Squibb, Teva, Sanofi Aventis, Merck and Co., Glenmark Pharmaceuticals

Middle East and Africa Diabetes Drugs Treatment Industry

Country Covered: Saudi Arabia

Study Period: 2018 - 2029

Major Players: Boehringer Ingelheim, Astrazeneca, Eli Lilly, Sanofi, Novo Nordisk

MEA DPP-4 Inhibitors Market

Country Covered: Saudi Arabia

Study Period: 2019- 2029

Major Players: Merck, Novartis, Boehringer Ingelheim, AstraZeneca, Eli Lilly and Company

Middle East And Africa Meglitinide Industry

Country Covered: Saudi Arabia

Study Period: 2018 - 2029

Major Players: Novo Nordisk, Glenmark, Kissei, Novartis, Biocon

Middle East And Africa Alpha-Glucosidase Inhibitors Industry

Country Covered: Saudi Arabia

Study Period: 2018 - 2029

Major Players: Takeda, Pfizer, Bayer, SunPharma, Glenmark

Insulin Market

Country Covered: Saudi Arabia

Study Period: 2019 - 2029

Major Players: Novo Nordisk A/S, Eli Lilly and Company, Sanofi S.A., Biocon Limited, Pfizer Inc.

Diabetes Care Drugs Market

Country Covered: Saudi Arabia

Study Period: 2019 - 2029

Major Players: Novo Nordisk, Sanofi, AstraZeneca, Boehringer Ingelheim, Eli Lilly and Company

DPP4 Drugs Industry

Country Covered: Saudi Arabia

Study Period: 2018 - 2029

Major Players: Merck, AstraZeneca, Boehringer Ingelheim Pharmaceuticals Inc., Pfizer Inc., Eli Lilly and Company

GLP-1 Agonists Market

Country Covered: Saudi Arabia

Study Period: 2019- 2029

Major Players: AstraZeneca, Eli Lilly and Company, Sanofi, Novo Nordisk A/S, Pfizer Inc.

Oral Antidiabetic Drugs Market

Country Covered: Saudi Arabia

Study Period: 2018 - 2029

Major Players: Eli Lilly and Company, Astellas Pharma Inc., Sanofi S.A., Janssen Pharmaceuticals, AstraZeneca

Alpha Glucosidase Inhibitor Drugs Market

Country Covered: Saudi Arabia

Study Period: 2018 - 2029

Major Players: Sun Pharma, Bayer, Takeda, Torrent Pharmaceuticals, Pfizer Inc.

Biguanides Market

Country Covered: Saudi Arabia

Study Period: 2018 - 2029

Major Players: Bristol Myers Squibb, Glenmark Pharmaceuticals, Takeda, Sanofi Aventis, Merck and Co.

Diabetes Combination Drugs Market

Country Covered: Saudi Arabia

Study Period: 2019- 2029

Major Players: Boehringer Ingelheim, Sanofi Aventis, Merck & Co., Inc., Eli Lilly and Company, Novo Nordisk A/S

Meglitinides Market

Country Covered: Saudi Arabia

Study Period: 2019- 2029

Major Players: Glenmark Pharmaceuticals, Novartis, Kissei Pharmaceuticals, Biocon, Novo Nordisk A/S

Sulfonylureas Industry

Country Covered: Saudi Arabia

Study Period: 2019- 2029

Major Players: Sanofi Aventis, Pfizer Inc., Merck & Co., Inc., Torrent Pharma, Dr. Reddy's Laboratories

SGLT2 Inhibitors Market

Country Covered: Saudi Arabia

Study Period: 2019 - 2029

Major Players: Janssen Pharmaceuticals, Eli Lilly, Bristol Myers Squibb, AstraZeneca Pharmaceuticals, Astellas

Basal Insulin (Long-Acting Insulin) Market

Country Covered: Saudi Arabia

Study Period: 2019 - 2029

Major Players: Novo Nordisk, Sanofi, Eli Lilly, Biocon, Wockhardt

Glargine Insulin Market

Country Covered: Saudi Arabia

Study Period: 2018 - 2029

Major Players: Sanofi Aventis, Novo Nordisk AS, Biocon, Eli Lilly and Company, Julphar

Wegovy Market

Country Covered: Saudi Arabia

Study Period: 2019 - 2029

Major Players: Novo Nordisk A/S

Ozempic Market

Country Covered: Saudi Arabia

Study Period: 2018-2029

Major Players: Novo Nordisk A/S

Liraglutide Market

Country Covered: Saudi Arabia

Study Period: 2018-2029

Major Players: Novo Nordisk A/S

Injectable Anti-diabetic Drugs Market

Country Covered: Saudi Arabia

Study Period: 2018-2029

Major Players: Novo Nordisk, Lilly, Julphar, Biocon, Sanofi

Trulicity Market

Country Covered: Saudi Arabia

Study Period: 2021-2029

Major Players: Eli Lilly